DIS3L inhibitors represent a specialized class of compounds that target the DIS3-like exonuclease, a member of the exosome complex responsible for RNA degradation. The DIS3L protein is a paralog of DIS3, sharing structural similarities but with distinct substrate preferences and biological roles. Both proteins are part of the RNA exosome complex, which is essential for processing and degrading various RNA species within the cell, including mRNA, rRNA, and small nuclear RNAs (snRNA). By inhibiting DIS3L, compounds in this class affect the regulation of RNA metabolism, specifically through their action on exoribonucleolytic activity. The core function of DIS3L is associated with 3'-5' exonucleolytic degradation, meaning it processes RNA molecules by trimming them from their 3' end towards the 5' end, maintaining cellular RNA homeostasis.
The chemical structures of DIS3L inhibitors are typically designed to mimic substrates of the DIS3L exonuclease or to bind at its active site in such a way that disrupts its enzymatic function. This disruption can lead to alterations in RNA processing and degradation, which in turn impacts the regulation of gene expression. Structurally, these inhibitors often contain moieties that interact with metal ions such as magnesium or manganese, which are necessary cofactors for the catalytic activity of DIS3L. By interfering with the coordination of these metal ions or directly occupying the enzyme's active site, DIS3L inhibitors can block the hydrolytic mechanism that normally breaks down RNA strands. The specificity of these inhibitors is critical, as targeting the exonuclease in a precise manner is necessary to achieve the desired alteration in RNA metabolism without affecting other components of the RNA exosome complex.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D inhibits RNA polymerase, affecting RNA synthesis and potentially impacting DIS3L's role in RNA turnover. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil inhibits thymidylate synthase, impacting RNA processing and stability, potentially influencing DIS3L. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin causes DNA damage, potentially influencing transcription and subsequent RNA turnover involving DIS3L. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB inhibits RNA polymerase II phosphorylation, affecting mRNA synthesis and possibly DIS3L activity. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Cordycepin, an adenosine analog, inhibits RNA synthesis, potentially impacting DIS3L-mediated RNA degradation. | ||||||
Spliceostatin A | 391611-36-2 | sc-507481 | 1 mg | $1800.00 | ||
Spliceostatin A affects mRNA splicing, potentially altering the types of RNA substrates available for DIS3L. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin, an anthracycline antibiotic, causes DNA damage, potentially influencing RNA processing and DIS3L activity. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Mycophenolic Acid inhibits inosine monophosphate dehydrogenase, potentially impacting RNA synthesis and DIS3L activity. | ||||||